The company’s $18 million Series A is intended to fund expansion into Southeast Asia and development of diagnostic-imaging software for resource-limited and rural healthcare settings. The page says the bet could improve access to AI-enhanced diagnosis and outcomes in underserved regions, while noting that adoption will depend on provider partnerships, staff training, systems integration, privacy, bias, and regulatory approval.